Trial NCT00738699

View at ClinicalTrials.gov 
Org. Study IDs: MORAb003-003PR

Last trial update was posted on 2017-03-30

MeSH Interventions

Albumin-Bound Paclitaxel Farletuzumab Paclitaxel

MeSH Conditions

Carcinoma, Ovarian Epithelial Ovarian Neoplasms

Other Conditions

Ovarian Cancer

Stopping Reasons

study did not meet pre-specified criteria for continuation following interim futility analysis

Limitations And Caveats

This study was prematurely terminated by the sponsor following results of the preplanned futility analysis showing the study was unlikely to meet its statistically-defined coprimary endpoints.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID